MarketPeel
Insider Trading Intelligence
DM

David Mehalick

COEP
CEO AND PRESIDENT · COEPTIS THERAPEUTICS HOLDINGS, INC. · CIK 0001846623
FILING MIX · LIFETIME80%/20%
BUYS
8
SELLS
2
TOTAL VALUE
$1.07M
COMPANIES
1
ACTIVE SINCE
Nov 2021
HOLDINGS NOW
330,192
AVG SELL PX
TRADE KIND
SHOWING 10 / 10
Trades · vs SPY
Loading price series…
Performance · forward returns vs SPY
4 backtested trades · 8 horizonsHow are these numbers computed? →
Forward-return performance of every backtestable P/S trade by David Mehalick, measured at 8 horizons from 7 days to 2 years. Deduped per economic event so co-filings count once. Excess return = trade return minus SPY return over the same window.
HORIZONTRADESWIN RATEINSIDER RETURNSPY RETURNMEAN EXCESSMEDIAN EXCESST-STAT
7d4+0.00%-9.50%+0.44%-9.95%-13.35%
14d4+0.00%-13.59%+0.98%-14.56%-19.03%
30d4+0.00%-15.37%+3.64%-19.01%-24.43%
60d4+0.00%-19.83%+5.85%-25.69%-33.85%
90d4+0.00%-36.77%+5.79%-42.55%-57.38%
180d4+0.00%-43.90%+9.91%-53.81%-75.67%
1y4+25.00%-58.98%+16.23%-75.21%-75.24%
2y4+100.00%-13.14%+35.86%-49.00%-38.12%
How to read this: Insider Returnis the average raw return of the filer's trades over the horizon. SPY Return is what SPY did over those same windows — reference only, not a comparison. The headline alpha number is Mean Excess = Insider − SPY; green means the filer beat SPY, red means they trailed it. Win rate is the share of individual trades where the filer beat SPY. T-statvalues above 2 mean the alpha is unlikely to be chance given the sample size. "Pending" counts trades where the horizon hasn't elapsed yet; their stats are not included in the row average.
Holdings over time
COEP · 330,192 shares · as of Feb 11, 2026
0695,6541,391,3082,086,9612,782,61520222023202420252026SHARES HELD
Trading cadence · quarterly flow
BUY SELL
2021
2022
2022
2022
2022
2023
2023
2023
2023
2024
2024
2024
2024
2025
2025
2025
2025
2026
FLOW · 8 buys / 2 sellsCOVERAGE · 18 quarters
Form 4 filings · all activity
COMPANYTYPESHARESPRICEVALUEHELD AFTERTRADE DATEFILEDDETAILS
COEP
COEPTIS THERAPEUTICS HOLDINGS, INC.
PURCHASEGRANT
Stock grant
51,250330,192Feb 11, 2026Feb 13, 2026View →
COEP
COEPTIS THERAPEUTICS HOLDINGS, INC.
PURCHASE
CEO and President
148,875$7.05$1.05M330,192Feb 11, 2026Feb 13, 2026View →
COEP
COEPTIS THERAPEUTICS HOLDINGS, INC.
PURCHASEGRANT
Stock grant
28,875200,125Mar 4, 2025Mar 6, 2025View →
COEP
COEPTIS THERAPEUTICS HOLDINGS, INC.
PURCHASE
CEO and President
6,000$0.67$4.0K2,768,611Jan 8, 2024Jan 9, 2024View →
COEP
COEPTIS THERAPEUTICS HOLDINGS, INC.
PURCHASE
CEO and President
14,004$0.66$9.2K2,782,615Jan 8, 2024Jan 9, 2024View →
COEP
COEPTIS THERAPEUTICS HOLDINGS, INC.
PURCHASE
CEO and President
5,050$0.69$3.5K2,762,611Jan 5, 2024Jan 9, 2024View →
COEP
COEPTIS THERAPEUTICS HOLDINGS, INC.
SALEGRANT
Gift
700,0002,757,561Dec 7, 2023Dec 11, 2023View →
COEP
COEPTIS THERAPEUTICS HOLDINGS, INC.
PURCHASEGRANT
Stock grant
250,000250,000Jan 27, 2023Jan 31, 2023View →
COEP
COEPTIS THERAPEUTICS HOLDINGS, INC.
PURCHASEGRANT
Stock grant
375,000375,000Jan 27, 2023Jan 31, 2023View →
COEP
COEPTIS THERAPEUTICS HOLDINGS, INC.
SALE
CEO and President
1,200,0001,800,000Nov 16, 2021Nov 18, 2021View →
Other insiders · COEP
Loading peer insiders…
About this filer
CIK 0001846623
ROLE
CEO and President
PRIMARY
COEP
COMPANIES
1
ACTIVE SINCE
Nov 2021
MARKETPEEL · /INSIDER/0001846623DATA · SEC EDGAR · FORM 4 · CONSOLIDATED TAPE
FREE · DAILY · 6 AM ET

One short email. Insider buys, congressional trades, and plain-English analysis.

Feedback